The Memphis Business Journal reported on Harmonyx Diagnostic’s new genetic test for pain prescriptions: “One in three Americans report suffering from chronic pain. With the serious risks and side effects associated with most pain medications, the test can help ensure a prescription isn’t negatively affecting a patient. The test could also help decrease the rate of abuse and overdose of opioids.”
Read the entire story here: http://www.bizjournals.com/memphis/news/2015/08/05/harmonyx-launches-genetic-test-to-improve-process.html